Literature DB >> 6517048

Carrier screening for phenylketonuria: comparison of two discriminant analysis procedures.

C L Freehauf, D Lezotte, S I Goodman, E R McCabe.   

Abstract

Absence of a convenient, direct enzyme assay for detecting phenylketonuria (PKU) heterozygotes has resulted in continued effort to develop an accurate and reliable procedure to discriminate the heterozygous individual from the homozygous normal. Our study compares two statistical procedures that combine the semifasting plasma phenylalanine and tyrosine concentrations with the individuals' prior probability of being a heterozygous carrier in order to discriminate carriers from noncarriers. The results of this comparison indicate that the quadratic discriminant function is superior to the linear discriminant function as a method of carrier testing both in theory and in practice. An interactive computer system is described that facilitates the clinical utilization of the quadratic discriminant function.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6517048      PMCID: PMC1684636     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  10 in total

1.  The use of biochemical data in screening for mutant alleles and in genetic counselling.

Authors:  R J Gold; U R Maag; J L Neal; C R Scriver
Journal:  Ann Hum Genet       Date:  1974-01       Impact factor: 1.670

2.  Problems in the biochemical detection of heterozygotes for phenylketonuria.

Authors:  L Y Yakymyshyn; D W Reid; D J Campbell
Journal:  Clin Biochem       Date:  1972-03       Impact factor: 3.281

3.  Detection of phenylketonuric heterozygotes.

Authors:  S H Jackson; W B Hanley; T Gero; G D Gosse
Journal:  Clin Chem       Date:  1971-06       Impact factor: 8.327

4.  Heterogeneity in genetic control of phenylalanine metabolism in man.

Authors:  D Rosenblatt; C R Scriver
Journal:  Nature       Date:  1968-05-18       Impact factor: 49.962

5.  Reduction of plasma tyrosine by oral contraceptives and oestrogens: a possible consequence of tyrosine aminotransferase induction.

Authors:  D P Rose; D G Cramp
Journal:  Clin Chim Acta       Date:  1970-07       Impact factor: 3.786

6.  Plasma amino acid pattern in phenylketonuric heterozygotes during pregnancy.

Authors:  B Cabalska; I Nowaczewska; N Duczyńska
Journal:  Biochem Med       Date:  1982-06

7.  Determination of heterozygosity for phenylketonuria on the amino acid analyzer.

Authors:  T L Perry; S Hansen; B Tischler; R Bunting
Journal:  Clin Chim Acta       Date:  1967-10       Impact factor: 3.786

8.  Classic phenylketonuria: diagnosis through heterozygote detection.

Authors:  R F Griffin; L J Elsas
Journal:  J Pediatr       Date:  1975-04       Impact factor: 4.406

9.  Phenylketonuria heterozygote detection in families with affected children.

Authors:  T D Paul; I K Brandt; L J Elsas; C E Jackson; P Mamunes; C S Nance; W E Nance
Journal:  Am J Hum Genet       Date:  1978-05       Impact factor: 11.025

10.  Phenylalanine tolerance tests. In families with phenylketonuria and hyperphenylalaninemia.

Authors:  G C Cunningham; R W Day; J L Berman; D Y Hsia
Journal:  Am J Dis Child       Date:  1969-06
  10 in total
  2 in total

1.  A model of human phenylalanine metabolism in normal subjects and in phenylketonuric patients.

Authors:  S Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

2.  Heterozygous carriers of classical phenylketonuria in a sample of the Turkish population: detection by a spectrofluorimetric method.

Authors:  F Güneral; I Ozalp; H Tatlidil
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.